Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of AXIM Biotechnologies patents

List of AXIM Biotechnologies patents

List of 128 Technology patents

List of Peugeot patents

List of Simplehuman patents

CEOs of voice assistant companies

List of awards received by Jean-Pierre Papin

Patents where

Current Assignee

Name

is

AXIM Biotechnologies

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 10172786 Oral care composition comprising cannabinoids	Patent 10172786 was granted and assigned to AXIM Biotechnologies on January, 2019 by the United States Patent and Trademark Office.	AXIM Biotechnologies	AXIM Biotechnologies		United States Patent and Trademark Office	10172786	January 8, 2019
	‌ US Patent 10059684 Process to extract and purify Δ	Patent 10059684 was granted and assigned to AXIM Biotechnologies on August, 2018 by the United States Patent and Trademark Office.	AXIM Biotechnologies	AXIM Biotechnologies		United States Patent and Trademark Office	10059684	August 28, 2018
	‌ US Patent 10246431 Process to extract and purify Δ	Patent 10246431 was granted and assigned to AXIM Biotechnologies on April, 2019 by the United States Patent and Trademark Office.	AXIM Biotechnologies	AXIM Biotechnologies		United States Patent and Trademark Office	10246431	April 2, 2019
	‌ US Patent 10272051 Method to treat atopic dermatitis	Patent 10272051 was granted and assigned to AXIM Biotechnologies on April, 2019 by the United States Patent and Trademark Office.	AXIM Biotechnologies	AXIM Biotechnologies		United States Patent and Trademark Office	10272051	April 30, 2019
	‌ US Patent 10092538 Suppositories comprising cannabinoids	Patent 10092538 was granted and assigned to AXIM Biotechnologies on October, 2018 by the United States Patent and Trademark Office.	AXIM Biotechnologies	AXIM Biotechnologies		United States Patent and Trademark Office	10092538	October 9, 2018
	‌ US Patent 9814695 Ophthalmic solutions for glaucoma and conjunctivitis treatment	Patent 9814695 was granted and assigned to AXIM Biotechnologies on November, 2017 by the United States Patent and Trademark Office.	AXIM Biotechnologies	AXIM Biotechnologies		United States Patent and Trademark Office	9814695	November 14, 2017
	‌ US Patent 9844530 Ophthalmic solutions for glaucoma and conjunctivitis treatment	Patent 9844530 was granted and assigned to AXIM Biotechnologies on December, 2017 by the United States Patent and Trademark Office.	AXIM Biotechnologies	AXIM Biotechnologies		United States Patent and Trademark Office	9844530	December 19, 2017
	‌ US Patent 10543190 Suppositories comprising cannabinoids	Patent 10543190 was granted and assigned to AXIM Biotechnologies on January, 2020 by the United States Patent and Trademark Office.	AXIM Biotechnologies	AXIM Biotechnologies		United States Patent and Trademark Office	10543190	January 28, 2020
	‌ US Patent 10441552 Anti-microbial composition comprising cannabinoids	Patent 10441552 was granted and assigned to AXIM Biotechnologies on October, 2019 by the United States Patent and Trademark Office.	AXIM Biotechnologies	AXIM Biotechnologies		United States Patent and Trademark Office	10441552	October 15, 2019

9 results

0 selected

9 results

0 selected